​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter (BAX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $19.75, with a high of $25.00 and a low of $15.00. This represents a 11.64% increase from the last price of $17.69.

$15 $22 $29 $36 $43 $50 High: $25 Avg: $19.75 Low: $15 Last Closed Price: $17.69

BAX Stock Rating

Baxter stock's rating consensus is Hold, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (41.67%), 20 Hold (55.56%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Hold
Total 36 1 20 15 Strong Sell Sell Hold Buy Strong Buy

BAX Price Target Upside V Benchmarks

TypeNameUpside
StockBaxter11.64%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks20.43%

Price Target Trends

1M3M12M
# Anlaysts6914
Avg Price Target$20.00$21.78$22.50
Last Closing Price$17.69$17.69$17.69
Upside/Downside13.06%23.12%27.19%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2612131-17
Feb, 2612131-17
Jan, 2612131-17
Dec, 2512131-17
Nov, 2512131-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026Goldman Sachs$17.00$20.54-17.23%-3.90%
Feb 16, 2026Danielle AntalffyUBS$19.00$19.79-3.99%7.41%
Feb 13, 2026Deutsche Bank$20.00$19.234.00%13.06%
Feb 13, 2026Barclays$25.00$18.7133.62%41.32%
Feb 12, 2026Jefferies$19.00$18.711.55%7.41%
Feb 12, 2026Stifel Nicolaus$20.00$18.716.89%13.06%
Jan 09, 2026Matt MiksicBarclays$30.00$20.6945.00%69.59%
Jan 09, 2026Goldman Sachs$23.00$20.6911.16%30.02%
Jan 05, 2026Vijay KumarEvercore ISI$23.00$20.0314.83%30.02%
Dec 02, 2025Patrick WoodMorgan Stanley$15.00$19.08-21.38%-15.21%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 16, 2026UBSNeutralNeutralhold
Jan 09, 2026BarclaysOverweightOverweighthold
Jan 09, 2026Goldman SachsNeutralNeutralhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Dec 11, 2025CitigroupNeutralNeutralhold
Dec 02, 2025Morgan StanleyUnderweightUnderweighthold
Oct 31, 2025Goldman SachsNeutralNeutralhold
Oct 30, 2025Cowen & Co.HoldHoldhold
Jul 31, 2025Goldman SachsNeutralNeutraldowngrade
Jan 02, 2025Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$-5 $-2 $1 $4 $7 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.56$-4.83$5.25$-1.27$-1.87---
Avg Forecast$3.60$3.56$2.59$1.83$2.47$2.72$3.15$3.40
High Forecast$3.62$3.60$2.60$1.84$2.54$2.83$3.20$3.46
Low Forecast$3.57$3.48$2.58$1.82$2.40$2.63$3.05$3.30
Surprise %-28.89%-235.67%102.70%-169.40%-175.71%---

Revenue Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.15B$10.06B$10.36B$10.64B$352.00M---
Avg Forecast$12.57B$15.00B$14.74B$10.56B$11.22B$11.71B$12.30B$12.84B
High Forecast$12.63B$15.14B$14.82B$10.58B$11.34B$11.72B$12.33B$13.00B
Low Forecast$12.51B$14.75B$14.72B$10.52B$11.00B$11.70B$12.27B$12.56B
Surprise %-3.38%-32.94%-29.72%0.75%-96.86%---

Net Income Forecast

$-3B $-1B $-300M $800M $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.28B$-2.43B$2.66B$-649.00M$1.14B---
Avg Forecast$1.17B$1.02B$-76.00M$924.32M$1.25B$1.38B$1.58B$1.72B
High Forecast$1.40B$1.23B$-60.80M$929.37M$1.29B$1.43B$1.62B$1.75B
Low Forecast$935.04M$818.87M$-91.20M$919.27M$1.21B$1.33B$1.55B$1.67B
Surprise %9.86%-337.69%-3594.74%-170.21%-9.12%---

BAX Forecast FAQ

Is Baxter stock a buy?

Baxter stock has a consensus rating of Hold, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 20 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Baxter is a neutral investment for most analysts.

What is Baxter's price target?

Baxter's price target, set by 36 Wall Street analysts, averages $19.75 over the next 12 months. The price target range spans from $15 at the low end to $25 at the high end, suggesting a potential 11.64% change from the previous closing price of $17.69.

How does Baxter stock forecast compare to its benchmarks?

Baxter's stock forecast shows a 11.64% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (20.43%).

What is the breakdown of analyst ratings for Baxter over the past three months?

  • March 2026: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.
  • February 2026: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.
  • January 2026: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.

What is Baxter’s EPS forecast?

Baxter's average annual EPS forecast for its fiscal year ending in December 2026 is $2.72, marking a -245.45% decrease from the reported $-1.87 in 2025. Estimates for the following years are $3.15 in 2027, and $3.4 in 2028.

What is Baxter’s revenue forecast?

Baxter's average annual revenue forecast for its fiscal year ending in December 2026 is $11.71B, reflecting a 3227.23% increase from the reported $352M in 2025. The forecast for 2027 is $12.3B, and $12.84B for 2028.

What is Baxter’s net income forecast?

Baxter's net income forecast for the fiscal year ending in December 2026 stands at $1.38B, representing an 21.50% increase from the reported $1.14B in 2025. Projections indicate $1.58B in 2027, and $1.72B in 2028.